Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.35B | 15.84B | 14.70B | 15.39B | 14.88B | 13.77B |
Gross Profit | 2.29B | 2.44B | 2.13B | 2.22B | 2.37B | 2.19B |
EBITDA | 812.30M | 1.35B | 793.97M | 1.17B | 1.37B | 1.30B |
Net Income | -141.05M | -132.85M | -243.87M | 189.19M | 417.23M | 350.07M |
Balance Sheet | ||||||
Total Assets | 14.40B | 14.09B | 14.60B | 13.36B | 12.89B | 13.24B |
Cash, Cash Equivalents and Short-Term Investments | 1.50B | 1.62B | 1.80B | 1.54B | 1.95B | 1.95B |
Total Debt | 4.10B | 3.93B | 4.68B | 3.96B | 4.64B | 5.40B |
Total Liabilities | 9.05B | 8.62B | 9.36B | 8.40B | 8.42B | 9.30B |
Stockholders Equity | 4.03B | 4.06B | 4.04B | 3.90B | 3.65B | 3.23B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 589.59M | -410.81M | 306.30M | 862.79M | 212.67M |
Operating Cash Flow | 0.00 | 1.44B | 1.41B | 905.90M | 1.09B | 627.64M |
Investing Cash Flow | 0.00 | -1.18B | -1.86B | -609.99M | -384.26M | -387.52M |
Financing Cash Flow | 0.00 | -891.48M | 610.11M | -812.14M | -908.17M | 917.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥9.85B | 6.88 | 5.54% | 1.02% | -5.01% | ||
76 Outperform | ¥9.56B | 4.81 | 5.61% | 1.49% | 78.77% | ||
72 Outperform | ¥10.01B | 5.54 | 3.70% | -4.87% | -19.11% | ||
63 Neutral | ¥12.36B | ― | 3.10% | 0.69% | -511.38% | ||
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
60 Neutral | ¥10.33B | 47.19 | 5.55% | -1.39% | -116.65% | ||
52 Neutral | ¥8.43B | ― | ― | 7.79% | 56.57% |